Myotec S 360mg Tablet contains 360mg of Mycophenolate sodium as the active ingredient. This medication is primarily indicated for the prevention of organ rejection in patients undergoing allogeneic transplantation, such as kidney, heart, or liver transplantation. Myotec S is an immunosuppressant that inhibits the proliferation of T and B lymphocytes, thereby reducing the activity of the immune system. It is crucial to administer Myotec S in combination with other immunosuppressants and corticosteroids for optimal effectiveness. The recommended dosage should be individualized based on the patient's renal function, transplant type, and overall clinical status. Adverse effects may include gastrointestinal disturbances, infections, anemia, and increased susceptibility to malignancy. Regular monitoring of blood counts, liver and kidney function, and viral load is necessary while on Myotec S therapy. Inform your healthcare provider about any concurrent medications, allergies, or pre-existing medical conditions before initiating treatment with Myotec S.